Joanne M. Donovan
Chief Tech/Sci/R&D Officer at EDGEWISE THERAPEUTICS, INC.
Net worth: 181 670 $ as of 2024-03-30
Profile
Joanne M.
Donovan is currently the Chief Medical Officer at Edgewise Therapeutics, Inc. She previously worked as the Vice President-Clinical Development at Genzyme Corp.
from 1998 to 2011, and as the Chief Medical Officer & SVP-Clinical Development at Astria Therapeutics, Inc. from 2011 to 2021.
Prior to that, she worked as the Medical Director at GelTex Pharmaceuticals, Inc. and as an Associate Clinical Professor at Harvard Medical School.
Donovan holds a doctorate degree from both Massachusetts Institute of Technology and Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-08-16 | 9,960 ( 0.01% ) | 181 670 $ | 2024-03-30 |
Joanne M. Donovan active positions
| Companies | Position | Start |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-04-26 |
Former positions of Joanne M. Donovan
| Companies | Position | End |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-04-22 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2010-12-31 |
| Harvard Medical School | Corporate Officer/Principal | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Joanne M. Donovan
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| EDGEWISE THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Joanne M. Donovan
